Anxiety · participants with haematological malignancies
It is very uncertain whether yoga in addition to standard care changes anxiety Scale from: 20 to 80. Higher scores indicate higher levels… compared with standard care only (very low certainty).
1 finding from 1 review
MD 0.3
Studies not reported
Very low
Depressive symptoms · participants with haematological malignancies
It is very uncertain whether yoga in addition to standard care changes depression Scale from: 0 to 60. Higher scores indicate more… compared with standard care only (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Quality of sleep · participants with haematological malignancies
It is very uncertain whether yoga in addition to standard care changes quality of sleep Scale from: 0 to 21. Higher scores indicate a lower… compared with standard care only (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Work functioning · people with IA
1 finding from 1 review
Intervention not reported
SGRQ Scores range from 0 to 100, with higher scores indicating more limitations · 18 to 80 years of age with bronchiectasis
The intervention showed no clear difference in SGRQ Scores range from 0 to 100, with higher scores indicating more… (low certainty).
1 finding from 1 review
Disability (higher ratings mean greater disability). Various instruments were used, e.g. in Oswestry Disability Index > 6 months' post operative 0% (no disability) to 100% (bedridden) · participants with lumbar disc herniation
1 finding from 1 review
Health‐related quality of life European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). Scale from: 0 to 100 (a higher score means a better outcome) · patients with paroxysmal nocturnal hemoglobinuria
1 finding from 1 review
Fatigue · patients with paroxysmal nocturnal hemoglobinuria
1 finding from 1 review
Visual acuity · people with diabetic retinopathy
1 finding from 1 review
Pain Self reported measures FIQ pain, SF‐36 bodily pain and VAS (transformed range 0 to 100, higher scores mean more pain) · adults with fibromyalgia
1 finding from 1 review
Muscle strength · adults with fibromyalgia
1 finding from 1 review
Muscle strength · adults with fibromyalgia
1 finding from 1 review
Six‐minute walk distance · adults with fibromyalgia
1 finding from 1 review
Multidimensional function FIQ Total Score. Scale 0‐100 (lower scores indicate greater health) · adults with fibromyalgia
1 finding from 1 review
Physical function · adults with fibromyalgia
1 finding from 1 review
Leaving the study early (2‐10 weeks) vs. standard higher dose (> 7.5‐15 mg/day) · people with the acute phase of schizophrenia
It is very uncertain whether STANDARD LOWER DOSE (> 3 to 7.5 mg/day) changes leaving the study early (2‐10 weeks) vs. standard higher dose (>… compared with OTHER DOSES (very low certainty).
1 finding from 1 review
Global state: No clinically significant response (as defined by the original studies) · people with the acute phase of schizophrenia
It is very uncertain whether STANDARD LOWER DOSE (> 3 to 7.5 mg/day) changes global state: 1. No clinically significant response in global state… compared with OTHER DOSES (very low certainty).
1 finding from 1 review
Adverse effects: 1. Clinically significant extrapyramidal side effects (2‐10 weeks) vs. standard higher dose (> 7.5‐15 mg/day) · people with the acute phase of schizophrenia
It is very uncertain whether STANDARD LOWER DOSE (> 3 to 7.5 mg/day) changes adverse effects: 1. Clinically significant extrapyramidal side… compared with OTHER DOSES (very low certainty).
1 finding from 1 review
Pain VAS 0‐100 (higher means worse) · patients with osteoarthritis
1 finding from 1 review
Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with osteoarthritis
1 finding from 1 review